Cerenome (PSTV) Cost of Revenue (2011 - 2018)
Plus Therapeutics (PSTV) posted quarterly Cost of Revenue of $628000.0 for Q3 2018, up 28.95% year-over-year from $487000.0 in Q3 2017, and little changed quarter-over-quarter from $630000.0 in Q2 2018.
Cerenome (PSTV) Cost of Revenue (2011 - 2018) Analysis & Trends
Plus Therapeutics (PSTV) has reported Cost of Revenue for 8 consecutive years, with $628000.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Cost of Revenue rose 28.95% year-over-year to $628000.0; the TTM figure through Sep 2018 stood at $2.5 million (down 13.49% YoY), while the FY2018 annual figure was $1.1 million, down 12.9% from the prior year.
- Cost of Revenue steadied at $628000.0 in Q3 2018 per PSTV's latest filing, from $630000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $1.4 million in Q4 2014 and bottomed at $337000.0 in Q3 2014.
- Historically, Cost of Revenue has averaged $695894.7 across 5 years, with a median of $628000.0 in 2018.
- Annual changes were most pronounced in 2014 — Cost of Revenue plunged 63.8% — and 2015, when it jumped 69.19%.
- Plus Therapeutics' Cost of Revenue stood at $1.4 million in 2014, then sank by 44.14% to $791000.0 in 2015, then rose by 19.47% to $945000.0 in 2016, then sank by 33.02% to $633000.0 in 2017, then dropped by 0.79% to $628000.0 in 2018.
- Business Quant data shows PSTV's Cost of Revenue at $628000.0 in Q3 2018, $630000.0 in Q2 2018, and $579000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 628,000.00 |
| Sep 30, 2018 | 628,000.00 |
| Jun 30, 2018 | 630,000.00 |
| Jun 30, 2018 | 630,000.00 |
| Mar 31, 2018 | 579,000.00 |
| Mar 31, 2018 | 579,000.00 |
| Dec 31, 2017 | 633,000.00 |
| Dec 31, 2017 | 633,000.00 |
| Sep 30, 2017 | 487,000.00 |
| Sep 30, 2017 | 487,000.00 |
| Jun 30, 2017 | 707,000.00 |
| Jun 30, 2017 | 707,000.00 |
| Mar 31, 2017 | 716,000.00 |
| Mar 31, 2017 | 716,000.00 |
| Dec 31, 2016 | 945,000.00 |
| Dec 31, 2016 | 945,000.00 |
| Sep 30, 2016 | 618,000.00 |
| Sep 30, 2016 | 618,000.00 |
| Jun 30, 2016 | 585,000.00 |
| Jun 30, 2016 | 585,000.00 |